Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial on the Safety and Efficacy of C1 Inhibitor for the Acute Management of Severe Traumatic Brain Injury

NCT04489160 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT04489160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04489160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial on the Safety and Efficacy of C1 Inhibitor for the Acute Management of Severe Traumatic Brain Injury
Lead sponsor
Leiden University Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
February 25, 2021
Completion date
July 31, 2024
Enrollment
106 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

trauma, head, traumatic brain injury